Neogenix Oncology Inc — Form D

Neogenix Oncology Inc of Great Neck, NY, a company, filed a Form D exempt-offering notice with the SEC on 2009-05-15. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2009-05-15
• Form: D
• Accession: 0001144204-09-027368
• Industry: Biotechnology
• Exemptions: 06
• Total offering: $15.0M
• Amount sold: $15.0M
• Minimum investment: $5K
• Investors: 308
• Date of first sale: 2008-07-01
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-82031

Issuer

• Name: Neogenix Oncology Inc
• CIK: 0001341293
• Entity type: Corporation
• Jurisdiction: MD
• Address: 445 Northern Boulevard, Great Neck, NY, 11021
• Phone: (516) 482-1200

Officers, directors & promoters (25)

Other filings by this issuer (3)

More

• CIK 1341293 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search